Findings from the first study to incorporate a meta-analysis on TNFi dose adjustment in an axSpA population.
Recent studies identify a counterintuitive risk factor, as well as 2 predictors of accelerated knee osteoarthritis.
Seropositivity was strongly associated with ILD risk in this large prospective cohort study.
What’s new in Sjögren syndrome: (1) clinical clues herald progression to a life-threatening variant and (2) a common therapy exacerbates comorbidities.
British researchers quantified the burden of continuing weight gain on the risk of PsA.
Recent studies explore the vascular underpinnings of neuropsychiatric damage as well as the risk of resistant hypertension in patients with SLE.
Be alert for the development of uveitis in older patients with gout, especially those who have multiple comorbidities.
Five questions to test your knowledge of the prevalence, risk, and classification of RA.
Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis Gets FDA Nod
The approval is based on data from two randomized, sham injection-controlled, double-masked phase 3 clinical trials with patient follow-up for 3 years.
Concerns have been raised in the past about the possibility of infection caused by immune suppression.